T-cell engagers, especially BiTEs, show promise in treating solid tumors by targeting tumor-associated antigens and redirecting T-cell activity. Tarlatamab, targeting DLL3 in SCLC, demonstrated ...
We've been using one word to describe two opposite nervous system reactions. The confusion is real—and it's keeping you from ...
Congress failed to reach a funding deal by Wednesday morning's deadline, leading to a government shutdown that will force active-duty service members to continue to serve without pay until a deal is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback